Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James Miller

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2533
2.540
Why?
Smoking
20
2019
1610
1.190
Why?
Bronchi
13
2018
269
1.160
Why?
Carcinoma in Situ
5
2019
44
1.070
Why?
Carcinoma, Squamous Cell
10
2018
637
0.740
Why?
Carcinogens
4
2012
126
0.730
Why?
Chemoprevention
3
2019
93
0.700
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
85
0.700
Why?
Lung
16
2020
4103
0.580
Why?
Carcinoma, Small Cell
7
2008
171
0.480
Why?
Bronchoscopy
9
2019
225
0.470
Why?
Urethane
3
2012
43
0.460
Why?
Bronchopulmonary Dysplasia
2
2019
387
0.460
Why?
Sputum
8
2019
305
0.450
Why?
Iloprost
2
2012
45
0.440
Why?
Pulmonary Alveoli
4
2012
408
0.440
Why?
Hyperplasia
7
2011
176
0.440
Why?
Precancerous Conditions
7
2020
165
0.420
Why?
Neprilysin
3
1998
45
0.410
Why?
Quinazolines
2
2012
249
0.380
Why?
Biomarkers, Tumor
7
2015
1229
0.380
Why?
Biopsy
11
2019
1072
0.380
Why?
Piperidines
2
2012
216
0.370
Why?
Antineoplastic Agents
4
2013
2152
0.370
Why?
DNA Copy Number Variations
1
2011
179
0.340
Why?
Bombesin
5
1998
11
0.330
Why?
Genetic Markers
1
2011
344
0.330
Why?
Amidohydrolases
3
1998
31
0.320
Why?
Neurosecretory Systems
4
2004
31
0.310
Why?
Isotretinoin
1
2009
24
0.310
Why?
Ki-67 Antigen
3
2015
111
0.310
Why?
Tocopherols
1
2009
26
0.300
Why?
Vasodilator Agents
1
2011
329
0.300
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
1111
0.300
Why?
ErbB Receptors
1
2012
610
0.300
Why?
Membrane Proteins
2
2008
1149
0.280
Why?
Neovascularization, Pathologic
6
2015
296
0.280
Why?
Mass Screening
3
2008
1296
0.270
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
1045
0.270
Why?
Respiratory Mucosa
2
2008
322
0.250
Why?
Adenocarcinoma
6
2012
882
0.240
Why?
Hypoxia
1
2012
1148
0.220
Why?
Chromosomes, Human, Pair 3
4
2000
47
0.220
Why?
Carcinoma, Bronchogenic
2
2002
20
0.210
Why?
Chromosome Aberrations
4
2013
159
0.200
Why?
Middle Aged
28
2019
33782
0.190
Why?
Tomography, Spiral Computed
1
2002
32
0.190
Why?
Aged
25
2019
24172
0.190
Why?
Humans
53
2020
138972
0.180
Why?
Sensitivity and Specificity
10
2010
1939
0.180
Why?
Smokers
2
2019
144
0.180
Why?
Female
33
2019
74016
0.170
Why?
Placebos
2
2019
197
0.170
Why?
Lung Diseases
5
2015
782
0.170
Why?
Double-Blind Method
2
2019
1949
0.170
Why?
Small Cell Lung Carcinoma
2
2012
115
0.170
Why?
Tomography, X-Ray Computed
2
2020
2697
0.160
Why?
Male
30
2019
68250
0.160
Why?
Neuropeptides
4
1998
75
0.150
Why?
Tumor Cells, Cultured
6
1998
956
0.150
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
115
0.150
Why?
Remission Induction
1
2019
292
0.150
Why?
In Situ Hybridization, Fluorescence
6
2010
310
0.140
Why?
Peptides
3
1996
980
0.140
Why?
Blotting, Western
4
2012
1232
0.140
Why?
Genes, p53
1
1997
68
0.140
Why?
Lung Diseases, Obstructive
1
1997
47
0.130
Why?
Immunohistochemistry
8
2015
1730
0.130
Why?
Antibodies, Monoclonal
3
2010
1437
0.130
Why?
Point Mutation
1
1997
238
0.130
Why?
Proteomics
2
2015
1112
0.120
Why?
Radiation Injuries, Experimental
1
1996
22
0.120
Why?
Bradykinin
1
1996
46
0.120
Why?
Endopeptidases
1
1996
87
0.120
Why?
Chromosomal Instability
2
2013
20
0.120
Why?
Smoking Cessation
1
2019
436
0.120
Why?
Multiple Pulmonary Nodules
1
2015
21
0.110
Why?
Hyperoxia
1
1996
91
0.110
Why?
Mice
10
2012
17828
0.110
Why?
Animals
13
2013
37243
0.110
Why?
Gene Expression
3
1998
1487
0.110
Why?
Methylcholanthrene
2
2012
22
0.110
Why?
Antigens
1
1996
356
0.110
Why?
Butylated Hydroxytoluene
2
2012
37
0.110
Why?
Mice, Transgenic
5
2009
2171
0.110
Why?
Risk Factors
5
2019
10385
0.100
Why?
Microarray Analysis
1
2013
116
0.100
Why?
Stem Cells
1
2018
599
0.100
Why?
Algorithms
3
2020
1730
0.100
Why?
Mutation
4
2000
3984
0.100
Why?
Aged, 80 and over
8
2015
7685
0.100
Why?
Epithelium
4
2018
316
0.100
Why?
Intramolecular Oxidoreductases
2
2004
68
0.100
Why?
Carcinoma, Large Cell
1
2012
15
0.100
Why?
Risk
5
2012
913
0.100
Why?
Biological Products
1
1996
226
0.100
Why?
Cytochrome P-450 Enzyme System
2
2004
158
0.100
Why?
Epithelial Cells
3
2007
1103
0.090
Why?
Receptors, Bombesin
1
2012
2
0.090
Why?
Bronchoalveolar Lavage Fluid
3
2002
649
0.090
Why?
Immunoenzyme Techniques
1
2012
209
0.090
Why?
Volatile Organic Compounds
1
2012
61
0.090
Why?
Cell Division
4
2000
794
0.090
Why?
Case-Control Studies
8
2012
3574
0.090
Why?
Sleep Apnea Syndromes
1
2012
90
0.090
Why?
Dose-Response Relationship, Drug
2
2010
2047
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
54
0.090
Why?
Proto-Oncogene Proteins c-myc
1
2012
147
0.090
Why?
Eosinophilic Granuloma
1
1990
3
0.080
Why?
Veterans
1
2002
1481
0.080
Why?
Epithelial-Mesenchymal Transition
1
2012
210
0.080
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
246
0.080
Why?
Antioxidants
2
2012
593
0.080
Why?
Plants, Toxic
1
1989
25
0.080
Why?
Cell Line
5
2013
2879
0.080
Why?
Proteins
1
1996
1009
0.080
Why?
Calcium
1
1996
1188
0.080
Why?
Somatomedins
1
2009
28
0.080
Why?
Genome-Wide Association Study
2
2013
1391
0.080
Why?
Predictive Value of Tests
4
2009
2030
0.080
Why?
Disease Progression
5
2018
2752
0.080
Why?
Cell Proliferation
2
2018
2480
0.080
Why?
Bronchial Neoplasms
1
2009
16
0.080
Why?
Intracellular Signaling Peptides and Proteins
2
2011
464
0.070
Why?
Chromosome Deletion
1
1989
114
0.070
Why?
Adult
16
2018
38393
0.070
Why?
Neoplasms, Glandular and Epithelial
1
2009
49
0.070
Why?
Respiratory System
1
1989
157
0.070
Why?
GPI-Linked Proteins
1
2008
76
0.070
Why?
Airway Obstruction
3
2009
164
0.070
Why?
Neoplasm Invasiveness
4
2015
501
0.070
Why?
Fluorescence
3
2009
159
0.070
Why?
Polymorphism, Genetic
1
2011
624
0.070
Why?
Alkaline Phosphatase
1
2008
149
0.070
Why?
Spectral Karyotyping
1
2007
5
0.070
Why?
Isoenzymes
1
2008
304
0.070
Why?
Molecular Targeted Therapy
1
2010
413
0.070
Why?
Cell Transformation, Neoplastic
1
2009
333
0.070
Why?
Inflammation
1
2018
2853
0.070
Why?
Molecular Sequence Data
5
1998
2925
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
262
0.070
Why?
Fibroblasts
3
1998
1002
0.070
Why?
Pulmonary Surfactants
2
1999
104
0.070
Why?
Exons
2
1998
352
0.060
Why?
MicroRNAs
1
2012
676
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2138
0.060
Why?
Follow-Up Studies
2
2015
5152
0.060
Why?
Early Detection of Cancer
1
2010
429
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
850
0.060
Why?
ROC Curve
3
2015
564
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2008
429
0.060
Why?
Recombinant Proteins
3
1998
1355
0.060
Why?
Biomarkers
3
2010
4095
0.060
Why?
RNA, Messenger
3
1998
2815
0.060
Why?
Polymerase Chain Reaction
3
1998
1047
0.060
Why?
Growth Hormone-Releasing Hormone
1
2004
25
0.050
Why?
Acromegaly
1
2004
16
0.050
Why?
Protein Kinase Inhibitors
1
2010
907
0.050
Why?
Cytokines
1
2012
2083
0.050
Why?
Adrenocorticotropic Hormone
1
2004
148
0.050
Why?
Rats
4
2004
5591
0.050
Why?
Smoke
1
2004
145
0.050
Why?
Base Sequence
3
1998
2176
0.050
Why?
Solitary Pulmonary Nodule
1
2002
21
0.050
Why?
Neoplasm Recurrence, Local
1
2009
1058
0.050
Why?
Metaplasia
2
2018
58
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
550
0.050
Why?
Cross-Sectional Studies
2
2018
5530
0.050
Why?
Sex Factors
1
2007
2050
0.040
Why?
Hospitals, Veterans
1
2002
255
0.040
Why?
Pulmonary Fibrosis
2
1998
399
0.040
Why?
Radiation Dosage
1
2002
188
0.040
Why?
Reproducibility of Results
1
2008
3313
0.040
Why?
Gene Expression Regulation
1
1989
2591
0.040
Why?
Cohort Studies
4
2015
5744
0.040
Why?
Amino Acid Sequence
3
1994
2159
0.040
Why?
Gastrin-Releasing Peptide
2
1996
7
0.040
Why?
Autocrine Communication
1
1998
40
0.040
Why?
Desmoglein 3
1
2018
15
0.040
Why?
gamma Catenin
1
2018
13
0.040
Why?
Signal Transduction
3
1998
5092
0.040
Why?
Loss of Heterozygosity
2
2013
51
0.040
Why?
Light
1
2001
393
0.040
Why?
DNA Primers
2
1998
509
0.040
Why?
Feasibility Studies
1
2002
980
0.040
Why?
Bronchial Diseases
1
2018
37
0.040
Why?
Up-Regulation
2
2005
852
0.040
Why?
Paracrine Communication
1
1998
66
0.040
Why?
Neoplasm Transplantation
1
1998
249
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
1998
42
0.030
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
13
0.030
Why?
Polymorphism, Single-Stranded Conformational
1
1997
25
0.030
Why?
Cell Cycle Checkpoints
1
2018
97
0.030
Why?
Time
1
2018
88
0.030
Why?
Gene Expression Profiling
1
2005
1746
0.030
Why?
Genes, Tumor Suppressor
1
1998
81
0.030
Why?
Alveolitis, Extrinsic Allergic
1
1998
97
0.030
Why?
Polymorphism, Restriction Fragment Length
1
1997
68
0.030
Why?
Likelihood Functions
1
1998
143
0.030
Why?
DNA, Complementary
1
1998
275
0.030
Why?
Gene Expression Regulation, Enzymologic
1
1998
276
0.030
Why?
Codon
1
1997
91
0.030
Why?
Neoplasm Staging
2
2012
1370
0.030
Why?
Introns
1
1998
254
0.030
Why?
United States
2
2011
15074
0.030
Why?
Mice, Nude
1
1998
688
0.030
Why?
Membrane Glycoproteins
1
1999
501
0.030
Why?
Treatment Outcome
1
2011
10921
0.030
Why?
Immunoassay
2
1998
111
0.030
Why?
Enzyme Activation
1
1998
819
0.030
Why?
Incidence
3
2010
2830
0.030
Why?
RNA, Neoplasm
1
1996
80
0.030
Why?
Glycopeptides
1
1996
43
0.030
Why?
Image Processing, Computer-Assisted
1
2020
748
0.030
Why?
Mesothelioma
1
1996
45
0.030
Why?
Sequence Analysis, DNA
1
1998
824
0.030
Why?
Antigens, CD
2
1998
537
0.030
Why?
Proto-Oncogene Proteins
1
2018
621
0.030
Why?
Machine Learning
1
2020
516
0.030
Why?
Cell Cycle Proteins
1
2018
617
0.030
Why?
Databases, Factual
1
2020
1409
0.030
Why?
Receptors, Peptide
1
1994
19
0.030
Why?
Myelin Sheath
1
1996
164
0.030
Why?
Rh-Hr Blood-Group System
1
1994
14
0.030
Why?
Erythrocyte Membrane
1
1994
53
0.030
Why?
Blotting, Southern
1
1993
75
0.030
Why?
Blotting, Northern
1
1993
198
0.030
Why?
Prospective Studies
3
2012
7661
0.030
Why?
Neoplasm Metastasis
1
1996
667
0.030
Why?
DNA, Neoplasm
1
1993
158
0.020
Why?
Cells, Cultured
2
2007
4182
0.020
Why?
Solid Phase Microextraction
1
2012
9
0.020
Why?
Endoscopy
1
2015
320
0.020
Why?
Dinoprostone
2
2004
192
0.020
Why?
Fluorescent Antibody Technique
1
1993
386
0.020
Why?
Breath Tests
1
2012
76
0.020
Why?
Cloning, Molecular
1
1993
533
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2012
135
0.020
Why?
Colorado
1
2002
4543
0.020
Why?
Enzyme Inhibitors
1
1996
850
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2018
1395
0.020
Why?
Liver Neoplasms
1
1998
719
0.020
Why?
Iceland
1
2011
11
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
13
0.020
Why?
Spain
1
2011
45
0.020
Why?
Netherlands
1
2011
87
0.020
Why?
Respiratory Tract Diseases
1
1992
181
0.020
Why?
Cattle
1
1993
990
0.020
Why?
Administration, Oral
1
2012
787
0.020
Why?
Rats, Sprague-Dawley
1
1996
2497
0.020
Why?
Meta-Analysis as Topic
1
2011
186
0.020
Why?
Severity of Illness Index
1
2018
2849
0.020
Why?
Carrier Proteins
1
1994
737
0.020
Why?
Receptor, IGF Type 1
1
2009
64
0.020
Why?
Prognosis
2
2012
3995
0.020
Why?
Area Under Curve
1
2010
319
0.020
Why?
Flow Cytometry
1
1993
1192
0.020
Why?
International Agencies
1
2009
33
0.020
Why?
Cystic Fibrosis
1
1998
1100
0.020
Why?
Erythrocytes
1
1994
701
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
590
0.020
Why?
Mass Spectrometry
1
2010
739
0.020
Why?
Pilot Projects
1
2012
1765
0.020
Why?
Genome, Human
1
2009
418
0.020
Why?
Models, Statistical
1
2010
665
0.020
Why?
Genotype
1
2011
1849
0.010
Why?
Amino Acids
1
1989
497
0.010
Why?
Disease Models, Animal
1
1996
4316
0.010
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
108
0.010
Why?
Genomics
1
2009
797
0.010
Why?
Epoprostenol
1
2004
136
0.010
Why?
Bronchiolitis
1
2004
82
0.010
Why?
Autoantibodies
1
2010
1457
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
984
0.010
Why?
Fruit
1
2003
146
0.010
Why?
Vegetables
1
2003
161
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
761
0.010
Why?
Genetic Predisposition to Disease
1
2011
2362
0.010
Why?
Respiratory Function Tests
1
2004
561
0.010
Why?
Pituitary Neoplasms
1
2004
191
0.010
Why?
Adenoma
1
2004
223
0.010
Why?
Regression Analysis
1
2003
1021
0.010
Why?
Single-Blind Method
1
2001
286
0.010
Why?
Weight Gain
1
2004
538
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
50
0.010
Why?
Carcinoma
1
2001
230
0.010
Why?
RNA
1
2005
925
0.010
Why?
Bronchoscopes
1
1998
3
0.010
Why?
Endoglin
1
1998
18
0.010
Why?
Random Allocation
1
1998
362
0.010
Why?
Genetic Linkage
1
1998
289
0.010
Why?
Retrospective Studies
1
2015
15901
0.010
Why?
Reference Values
1
1998
801
0.010
Why?
Comorbidity
1
2001
1657
0.010
Why?
Linear Models
1
1998
855
0.010
Why?
Longitudinal Studies
1
2003
2850
0.010
Why?
Tumor Suppressor Protein p53
1
2000
527
0.010
Why?
Analysis of Variance
1
1998
1317
0.010
Why?
Diet
1
2003
1285
0.010
Why?
Receptors, Cell Surface
1
1998
394
0.010
Why?
Alleles
1
1998
890
0.010
Why?
Risk Assessment
1
2004
3466
0.010
Why?
Young Adult
1
2011
13371
0.010
Why?
Infant, Premature
1
1998
580
0.010
Why?
Chromatography, Affinity
1
1994
86
0.010
Why?
CD47 Antigen
1
1994
37
0.010
Why?
Endothelium, Vascular
1
2000
935
0.010
Why?
Genes
1
1994
227
0.010
Why?
Moths
1
1994
44
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
336
0.010
Why?
Cytoplasm
1
1994
270
0.010
Why?
Carcinoid Tumor
1
1992
23
0.010
Why?
Chromosome Mapping
1
1994
505
0.010
Why?
Lymphocytes
1
1994
395
0.010
Why?
Transfection
1
1994
942
0.010
Why?
Adolescent
1
2011
21581
0.010
Why?
Mice, Inbred BALB C
1
1994
1261
0.010
Why?
Dyspnea
1
1992
254
0.010
Why?
Binding Sites
1
1994
1317
0.010
Why?
Fibrosis
1
1992
539
0.010
Why?
Phenotype
1
1998
3143
0.000
Why?
Aging
1
1998
1857
0.000
Why?
Infant, Newborn
1
1998
6158
0.000
Why?
Infant
1
1998
9577
0.000
Why?
Child, Preschool
1
1998
11158
0.000
Why?
Child
1
1998
21936
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)